Global Anti–vascular Endothelial Growth Factor Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti–vascular Endothelial Growth Factor Therapy Market Insights, Forecast to 2034

Anti–vascular Endothelial Growth Factor Therapy is a medical treatment used primarily in ophthalmology to address conditions like age-related macular degeneration and diabetic retinopathy. It involves the use of drugs that inhibit VEGF, a protein responsible for promoting abnormal blood vessel growth. By reducing VEGF activity, the therapy aims to slow down the progression of these eye diseases and prevent vision loss.
Market Analysis and InsightsGlobal Anti–vascular Endothelial Growth Factor Therapy Market
Global Anti–vascular Endothelial Growth Factor Therapy market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Anti–vascular Endothelial Growth Factor Therapy industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Anti–vascular Endothelial Growth Factor Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Anti–vascular Endothelial Growth Factor Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company

Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
Segment by Type
Extraction Injection
Precharge Injection

Segment by Application

Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Anti–vascular Endothelial Growth Factor Therapy introduction, etc. Anti–vascular Endothelial Growth Factor Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Anti–vascular Endothelial Growth Factor Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Extraction Injection
1.2.3 Precharge Injection
1.3 Market by Application
1.3.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Macular Degeneration
1.3.3 Nacular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Perspective (2018-2029)
2.2 Global Anti–vascular Endothelial Growth Factor Therapy Growth Trends by Region
2.2.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Region (2018-2024)
2.2.3 Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2024-2029)
2.3 Anti–vascular Endothelial Growth Factor Therapy Market Dynamics
2.3.1 Anti–vascular Endothelial Growth Factor Therapy Industry Trends
2.3.2 Anti–vascular Endothelial Growth Factor Therapy Market Drivers
2.3.3 Anti–vascular Endothelial Growth Factor Therapy Market Challenges
2.3.4 Anti–vascular Endothelial Growth Factor Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Anti–vascular Endothelial Growth Factor Therapy by Players
3.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2018-2024)
3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio
3.4.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2022
3.5 Global Key Players of Anti–vascular Endothelial Growth Factor Therapy Head office and Area Served
3.6 Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Product and Application
3.7 Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Type
4.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Type (2018-2024)
4.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2024-2029)
5 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Application
5.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Application (2018-2024)
5.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size (2018-2029)
6.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
6.2.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024)
6.2.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029)
6.2.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
6.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
6.3.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024)
6.3.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029)
6.3.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
6.4 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
6.4.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024)
6.4.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size (2018-2029)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
7.2.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024)
7.2.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029)
7.2.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
7.3.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024)
7.3.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029)
7.3.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
7.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
7.4.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024)
7.4.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Anti–vascular Endothelial Growth Factor Therapy Market Size (2018-2029)
8.2 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
8.2.1 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024)
8.2.2 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029)
8.2.3 China Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
8.3 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
8.3.1 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024)
8.3.2 China Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029)
8.3.3 China Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size (2018-2029)
9.2 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
9.2.1 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024)
9.2.2 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029)
9.2.3 Asia Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
9.3 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
9.3.1 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024)
9.3.2 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029)
9.3.3 Asia Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
9.4 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region
9.4.1 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2024)
9.4.3 Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Company Details
11.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Introduction
11.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Genentech Business Overview
11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Introduction
11.2.4 Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
11.2.5 Genentech Recent Developments
11.3 Kanghong Pharmaceutical
11.3.1 Kanghong Pharmaceutical Company Details
11.3.2 Kanghong Pharmaceutical Business Overview
11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Introduction
11.3.4 Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
11.3.5 Kanghong Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Extraction Injection
Table 3. Key Players of Precharge Injection
Table 4. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2018-2024)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2024-2029)
Table 10. Anti–vascular Endothelial Growth Factor Therapy Market Trends
Table 11. Anti–vascular Endothelial Growth Factor Therapy Market Drivers
Table 12. Anti–vascular Endothelial Growth Factor Therapy Market Challenges
Table 13. Anti–vascular Endothelial Growth Factor Therapy Market Restraints
Table 14. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Share by Players (2018-2024)
Table 16. Global Top Anti–vascular Endothelial Growth Factor Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2022)
Table 17. Global Anti–vascular Endothelial Growth Factor Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Headquarters and Area Served
Table 20. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Product and Application
Table 21. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Share by Application (2018-2024)
Table 29. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Share by Application (2024-2029)
Table 31. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Anti–vascular Endothelial Growth Factor Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Anti–vascular Endothelial Growth Factor Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Anti–vascular Endothelial Growth Factor Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Regeneron Pharmaceuticals (Eylea) Company Details
Table 64. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 65. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product
Table 66. Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024) & (US$ Million)
Table 67. Regeneron Pharmaceuticals (Eylea) Recent Developments
Table 68. Genentech Company Details
Table 69. Genentech Business Overview
Table 70. Genentech Anti–vascular Endothelial Growth Factor Therapy Product
Table 71. Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024) & (US$ Million)
Table 72. Genentech Recent Developments
Table 73. Kanghong Pharmaceutical Company Details
Table 74. Kanghong Pharmaceutical Business Overview
Table 75. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product
Table 76. Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024) & (US$ Million)
Table 77. Kanghong Pharmaceutical Recent Developments
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Type: 2022 VS 2029
Figure 3. Extraction Injection Features
Figure 4. Precharge Injection Features
Figure 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2022 VS 2029
Figure 7. Macular Degeneration Case Studies
Figure 8. Nacular Edema Case Studies
Figure 9. Uveitis Case Studies
Figure 10. Retinal Vein Occlusion Case Studies
Figure 11. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 12. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Anti–vascular Endothelial Growth Factor Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region: 2022 VS 2029
Figure 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players in 2022
Figure 16. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2022
Figure 18. North America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
Figure 20. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
Figure 21. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2018-2029)
Figure 22. United States Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
Figure 26. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
Figure 27. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2018-2029)
Figure 28. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Anti–vascular Endothelial Growth Factor Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
Figure 36. China Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
Figure 37. Asia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
Figure 39. Asia Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
Figure 40. Asia Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2018-2029)
Figure 41. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2018-2029)
Figure 51. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
Figure 58. Genentech Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
Figure 59. Kanghong Pharmaceutical Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Global Anti–vascular Endothelial Growth Factor Therapy Market Insights, Forecast to 2034

Global Anti–vascular Endothelial Growth Factor Therapy Market Insights, Forecast to 2034

By Company

Segment by Application

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries